MARSHALL WACE, LLP - ALLAKOS INC ownership

ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 72 filers reported holding ALLAKOS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ALLAKOS INC
ValueSharesWeighting
Q1 2023$355,190
-24.4%
79,818
+43.1%
0.00%0.0%
Q4 2022$469,685
+0.6%
55,782
-32.0%
0.00%0.0%
Q1 2022$467,000
+102.2%
81,994
+4878.4%
0.00%0.0%
Q4 2020$231,000
+335.8%
1,647
+196.2%
0.00%
Q4 2019$53,000
+20.5%
5560.0%0.00%
Q3 2019$44,000
-93.8%
556
-96.8%
0.00%
-100.0%
Q1 2019$710,00017,5380.00%
Other shareholders
ALLAKOS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 270,965$12,055,0006.94%
NEA Management Company, LLC 2,268,188$100,912,0005.27%
Fairmount Funds Management LLC 178,662$7,949,0004.82%
Redmile Group, LLC 2,976,928$132,444,0003.71%
Boxer Capital, LLC 675,000$30,031,0002.05%
Rock Springs Capital Management LP 235,000$10,455,0000.43%
Cormorant Asset Management, LP 200,000$8,898,0000.41%
RAMIUS ADVISORS LLC 31,155$1,386,0000.35%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 15,700$692,0000.32%
Handelsinvest Investeringsforvaltning 20,000$890,0000.24%
View complete list of ALLAKOS INC shareholders